United Therapeutics (UTHR) Q4 Earnings & Sales Miss, Stock Down

Published on February 25, 2022

United Therapeutics (UTHR) fourth-quarter earnings and sales miss estimates. Higher sales of Tyvaso and Unituxin mainly drive the top line in the quarter, offset by lower sales of other drugs.

Continue reading on website
Other news

2 Best Waste Management Stocks to Own in 2022: Clean Harbors and Heritage-Crystal Clean

February 25, 2022
The need for advanced waste management has garnered immense attention from big market players amid increasing ESG investment trends. The sector is necessary to achieve sustainable growth. Thus, we think...

Here's How Nordstrom (JWN) Looks Just Ahead of Q4 Earnings

February 25, 2022
Nordstrom's (JWN) Q4 performance is expected to have gained from brand strength, digital momentum and a solid performance in the Nordstrom banner. Supply-chain woes are likely to have hurt.